Xia Wu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Advanced biosensing and bioanalysis techniques 9
- Inflammasome and immune disorders 8
- RNA modifications and cancer 7
- RNA Interference and Gene Delivery 6
- Oncology 21
- Cancer Immunotherapy and Biomarkers 8
- Viral-associated cancers and disorders 5
- Co-authors
- Qiaohong Wang (4 shared papers)Yiming Li (1 shared paper)Yanjun Zhong (1 shared paper)Yanbing Ding (1 shared paper)Junke Long (1 shared paper)Wen Di (4 shared papers)Lifang Yang (8 shared papers)Yuping Gong (10 shared papers)
- Journals
- Scientific Reports (5 papers)Medicine (3 papers)International Immunopharmacology (3 papers)PLoS ONE (3 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xia Wu
129 papers receiving 3.6k citations
Xia Wu's Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 504
- Oncology 796
- Infectious Diseases 389
- Immunology 444
- Molecular Biology 1.3k
Countries citing papers authored by Xia Wu
This map shows the geographic impact of Xia Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Wu more than expected).
Fields of papers citing papers by Xia Wu
This network shows the impact of papers produced by Xia Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Wu. The network helps show where Xia Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The epidemiology, diagnosis and treatment of COVID-19 Hit paper breakdown → | 2020 | 666 |
| 2 | Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer Hit paper breakdown → | 2021 | 218 |
| 3 | 2018 | 119 | |
| 4 | 2020 | 117 | |
| 5 | 2017 | 111 | |
| 6 | 2020 | 83 | |
| 7 | 2022 | 82 | |
| 8 | 2020 | 77 | |
| 9 | 2020 | 75 | |
| 10 | 2017 | 70 | |
| 11 | 2020 | 70 | |
| 12 | 2009 | 66 | |
| 13 | 2014 | 54 | |
| 14 | 2019 | 52 | |
| 15 | 2021 | 50 | |
| 16 | 2019 | 50 | |
| 17 | 2005 | 49 | |
| 18 | 2017 | 49 | |
| 19 | 2020 | 47 | |
| 20 | 2019 | 46 |
About Xia Wu
Xia Wu is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Pulmonary and Respiratory Medicine, having authored 139 papers that have together received 3.6k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Inflammasome and immune disorders (8 papers), Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (7 papers), RNA Interference and Gene Delivery (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Viral-associated cancers and disorders (5 papers). The work is most often cited by research in Cancer Research (504 citations), Oncology (796 citations), Infectious Diseases (389 citations), Immunology (444 citations) and Molecular Biology (1.3k citations). Xia Wu has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Qiaohong Wang, Yiming Li, Yanjun Zhong, Yanbing Ding, Junke Long, Wen Di, Lifang Yang, Yuping Gong, Zhuan Zhou and Jinwu Peng. Their work appears in journals such as Scientific Reports, Medicine, International Immunopharmacology, PLoS ONE and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.